Assessing reperfusion and recanalization as markers of clinical outcomes after intravenous thrombolysis in the echoplanar imaging thrombolytic evaluation trial (EPITHET)

Stroke

Volumn 40, Issue 8, 2009, Pages 2872-2874

  De Silva, Deidre A ^a   Fink, John N ^b   Christensen, Soren ^a   Ebinger, Martin ^a   Bladin, Christopher ^c   Levi, Christopher R ^d   Parsons, Mark ^d   Butcher, Ken ^e   Barber, P Alan ^f   Donnan, Geoffrey A ^g,h   Davis, Stephen M ^a,h  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

^b UNIVERSITY OF OTAGO   (New Zealand)

^c Eastern Melbourne Neurosciences ^*  (Australia)

^d JOHN HUNTER HOSPITAL   (Australia)

^e UNIVERSITY OF ALBERTA   (Canada)

^f AUCKLAND CITY HOSPITAL   (New Zealand)

^g FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^h UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Clinical outcomes; Ischemic stroke; Recanalization; Reperfusion; Thrombolysis

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

ARTICLE; BLOOD CLOT LYSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CORRELATION ANALYSIS; ECHO PLANAR IMAGING; HUMAN; IMAGE ANALYSIS; MAGNETIC RESONANCE ANGIOGRAPHY; MAJOR CLINICAL STUDY; PERFUSION WEIGHTED IMAGING; PRIORITY JOURNAL; RECANALIZATION; REPERFUSION; STROKE; TREATMENT OUTCOME;

CATHETERIZATION; CEREBRAL REVASCULARIZATION; DOUBLE-BLIND METHOD; ECHO-PLANAR IMAGING; FIBRINOLYTIC AGENTS; HUMANS; INJECTIONS, INTRAVENOUS; PROSPECTIVE STUDIES; REPERFUSION; STROKE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 68749100880     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.108.543595     Document Type: Article

References (8)

1. Davis SM, Donnan GA, Parsons MW, Levi C, Butcher KS, Peeters A, Barber PA, Bladin C, De Silva DA, Byrnes G, Chalk JB, Fink JN, Kimber TE, Schultz D, Hand PJ, Frayne J, Hankey G, Muir K, Gerraty R, Tress BM, Desmond PM. Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial. Lancet Neurol. 2008;7:299-309.
2. Albers GW, Thijs VN, Wechsler L, Kemp S, Schlaug G, Skalabrin E, Bammer R, Kakuda W, Lansberg MG, Shuaib A, Coplin W, Hamilton S, Moseley M, Marks MP. Magnetic resonance imaging profiles predict clinical response to early reperfusion: the Diffusion and Perfusion Imaging Evaluation for Understanding Stroke Evolution (DEFUSE) study. Ann Neurol. 2006;60:508-517.
3. Rha JH, Saver JL. The impact of recanalization on ischemic stroke outcome: a meta-analysis. Stroke. 2007;38:967-973.
4. Khatri P, Neff J, Broderick JP, Khoury JC, Carrozzella J, Tomsick T. Revascularization end points in stroke interventional trials: recanalization versus reperfusion in IMS I. Stroke. 2005;36:2400-2403.
5. Hacke W, Albers G, Al-Rawi Y, Bogousslavsky J, Davalos A, Eliasziw M, Fischer M, Furlan A, Kaste M, Lees KR, Soehngen M, Warach S. The Desmoteplase In Acute ischemic Stroke trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke. 2005;36:66-73.
6. DIAS-3. Efficacy and Safety Study of Desmoteplase to Treat Acute IschemicStroke. Available at: www.strokecenter.org/trials/TrialDetail.aspx?tid= 914. Accessed February 28, 2009.
7. Molina CA, Montaner J, Abilleira S, Arenillas JF, Ribo M, Huertas R, Romero F, Alvarez-Sabin J. Time course of tissue plasminogen activatorinduced recanalization in acute cardioembolic stroke: a case-control study. Stroke. 2001;32:2821-2827.
8. Wunderlich MT, Goertler M, Postert T, Schmitt E, Seidel G, Gahn G, Samii C, Stolz E. Recanalization after intravenous thrombolysis: does a recanalization time window exist? Neurology. 2007;68:1364-1368.